JP4461468B2 - Process for producing N- (2-amino-1,2-dicyanovinyl) formic acid derivative - Google Patents

Process for producing N- (2-amino-1,2-dicyanovinyl) formic acid derivative Download PDF

Info

Publication number
JP4461468B2
JP4461468B2 JP2000116218A JP2000116218A JP4461468B2 JP 4461468 B2 JP4461468 B2 JP 4461468B2 JP 2000116218 A JP2000116218 A JP 2000116218A JP 2000116218 A JP2000116218 A JP 2000116218A JP 4461468 B2 JP4461468 B2 JP 4461468B2
Authority
JP
Japan
Prior art keywords
dicyanovinyl
amino
alcohol
formula
reaction
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
JP2000116218A
Other languages
Japanese (ja)
Other versions
JP2001302609A (en
Inventor
文彦 長崎
洋明 柴崎
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nippon Soda Co Ltd
Original Assignee
Nippon Soda Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to JP2000116218A priority Critical patent/JP4461468B2/en
Application filed by Nippon Soda Co Ltd filed Critical Nippon Soda Co Ltd
Priority to CNB2003101214353A priority patent/CN1238338C/en
Priority to CNB008131155A priority patent/CN1150169C/en
Priority to AT00961096T priority patent/ATE334972T1/en
Priority to PCT/JP2000/006397 priority patent/WO2001021592A1/en
Priority to DE60029803T priority patent/DE60029803T2/en
Priority to KR10-2002-7003643A priority patent/KR100538958B1/en
Priority to US10/088,425 priority patent/US6797828B1/en
Priority to EP00961096A priority patent/EP1215206B1/en
Publication of JP2001302609A publication Critical patent/JP2001302609A/en
Application granted granted Critical
Publication of JP4461468B2 publication Critical patent/JP4461468B2/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Description

【0001】
【発明の属する技術分野】
本発明は、医薬の中間体として有用なアルキルN−(2−アミノ−1,2−ジシアノビニル) ホルムイミデート(以下RMDという)及びN−(2−アミノ−1,2−ジシアノビニル) ホルムアミジン(以下AMDという)などのN−(2−アミノ−1,2−ジシアノビニル)ギ酸誘導体の簡便で効率のよい製造方法に関する。
【0002】
【従来の技術】
N−(2−アミノ−1,2−ジシアノビニル)ホルムアミジンは医薬の有用な中間体であり,例えば抗がん剤ダカルバジン(dacarbazine)及びテモゾロミド(temozoromide)、肝臓保護薬ウラザミド(urazamide)の前駆体である1H−4(5)−アミノイミダゾール−5(4)−カルボキサミド(本文中以下AICAと略す)の中間原料であり効率の良い合成法が求められていた。
【0003】
AMD及びRMDの合成方法としては、今までに以下の方法が知られている。
AMDについて、例えば、R.F.Shuman等(J.Org.Chem.,1979,44,4532)はジアミノマレオニトリル(本文中以下DAMNと略す)とホルムアミジン酢酸塩をエタノール中で還流温度で加熱する方法によりAMDを合成している。しかし収率はわずか2%であり、AMDの工業的製造法としては現実的でない。
【0004】
又、RMDについて、B.L.Booth等(J.Chem.Soc.Perkin Trans.I,1990,1705)は、ジアミノマレオニトリル(以下DAMNという)からエチルN−(2−アミノ−1,2−ジシアノビニル) ホルムイミデート(本文中以下EMDと略す)を合成し、次にEMDからAMDを合成する二工程の方法を報告している。すなわち、第一工程はジオキサン中でDAMNとトリエチルオルトホルメートを反応させてEMDを収率84%で合成し、第二工程でEMDとアンモニアの反応を、クロロホルム中でアニリン塩酸塩を触媒として用いて−20℃以下の低温で行なうことによりAMDを収率95%で合成している。
【0005】
【発明が解決しようとする課題】
しかし、この方法も反応操作の煩雑さ、低温反応、使用する溶媒種の多さ及びハロゲン系溶媒による環境汚染の可能性等、問題点が多数あり、工業的製造法としては不十分である。
以上述べたように、従来の技術において知られているRMD及びAMDの製造方法は、工業生産を想定すると満足できる方法ではない。
本発明は、RMD及びAMDを安価に効率よく製造する新規な製造方法を提供することを目的とする。
【0006】
【課題を解決するための手段】
本発明者等は、上記課題を解決するため鋭意検討した結果、DAMNとトリアルキルオルトホルメートからRMDを製造し、次にRMDとアンモニアからAMDを製造する二つの工程の反応において、アルコール脱離反応であり反応系からアルコールを除去する必要があるにも拘らず、アルコール系の溶媒を採用することにより従来技術の有する上述の問題点の多くを解決する方法を見出し、さらにRMDとAMDの製造工程において同種の溶媒を採用する事により安価で工業的製造に適した方法を見出し本発明を完成した。
【0007】
本発明は、RMD[アルキルN−(2−アミノ−1,2−ジシアノビニル) ホルムイミデート)]をC1〜C5アルコール中でアンモニアと反応させるAMD{(N−(2−アミノ−1,2−ジシアノビニル) ホルムアミジン}の製造方法であり、DAMN[ジアミノマレオニトリル]をC1〜C5アルコール中でトリアルキルオルトホルメートと反応させRMDを製造し、さらに、得られたRMDをC1〜C5アルコール中でアンモニアと反応させるAMDの製造方法であり、更に、DAMNをC1〜C5アルコール中でトリアルキルオルトホルメートと反応させるRMDの製造方法であり、それぞれの工程で使用するC1〜C5アルコールがメチルアルコール又はエチルアルコールである製造方法である。
【0008】
本発明の反応式を参考のために示すと次の通りである。
式中、Rは、低級アルキル基を示す。
【化1】
【0009】
【発明の実施の形態】
本発明に用いられるDAMNは、青酸の四量化反応から容易に合成することができ、また工業的に入手可能な出発原料である。もう一つの出発原料であるトリアルキルオルトホルメートも工業的に入手可能な出発原料である。
DAMNとトリルアルキルオルトホルメートからRMDを合成する反応はアルコール系溶媒中で室温ないし加熱して行なうことができる。アルコール系溶媒としては例えばメタノール、エタノール、n−プロパノール、i−プロパノール、、n−ブタノール、i−ブタノール、t−ブタノール等を例示することができるが、原料及び生成物の溶解度、回収蒸留の容易さ、価格等の面から特にメタノール、エタノールが好ましい。
【0010】
又、トリアルキルオルトホルメート又はRMD中のアルキル基は、C1〜5の低級アルキル基が好ましく、メチル、エチル、n−プロピル、i−プロピル、n−ブチル、i−ブチル、ペンチルなどであり、メチル又はエチルが最も好ましい。
更に、反応中に前記反応式に示される通り、使用した原料に由来する低級アルキルのアルコールが副生する。従って、使用するアルコール系溶媒としては、副生する低級アルキルのアルコールと同一とするのが、分離、回収上都合がいい。
反応温度は採用する反応時間によるが、低温では反応が遅く長時間を要し、高温では短時間で原料がなくなるが副生成物(主として環化生成物の4,5−ジシアノイミダゾール)の増加による純度低下に注意する必要がある。反応温度は室温から溶媒還流温度、反応時間は30分から10時間が好ましい。
【0011】
反応終了後RMDの単離は濾過により行なうが、溶媒に溶解しているRMDを減らし収率を向上させるために0℃から室温まで冷却して十分RMDを析出させておく事が好ましい。
このような方法により高純度のRMDが得られるが、更に純度を上げる必要がある場合には再結晶により精製することができる。
RMDとアンモニアからAMDを合成する反応のアルコール系溶媒としては例えばメタノール、エタノール、n−プロパノール、i−プロパノール、n−ブタノール、i−ブタノール、t−ブタノール等を例示することができるが、原料及び生成物の溶解度、回収蒸留の容易さ、価格等の面から特にメタノール、エタノールが好ましい。
【0012】
反応は冷却下でも溶媒還流温度でも進行するが、アンモニアの溶解度と溶解時の発熱等を考慮すると、冷却下で反応を開始することが好ましい。反応時間は30分から10時間が好ましい。
反応終了後AMDの単離は濾過により行なうが、溶媒に溶解しているAMDを減らし収率向上のためには、冷却してAMDを十分析出させておく事が好ましい。
このような方法により高純度のAMDが得られるが、更に高純度品が必要な場合には再結晶により精製することができる。
【0013】
以下、実施例により本発明を詳細に説明するが、本発明の範囲は実施例に限定されるものではない。
【0014】
【実施例】
実施例1
RMDのRがメチル基であるメチルN−(2−アミノ−1,2−ジシアノビニル)ホルムイミデートの合成
メタノール60mlにDAMN30.0g,トリメチルオルトホルメート32.4gを加え窒素雰囲気下65℃で2時間、加熱攪拌した。反応液を5℃まで冷却し析出した結晶を濾別しメタノール20mlで洗浄した。結晶を真空乾燥して33.6gのメチルN−(2−アミノ−1,2−ジシアノビニル) ホルムイミデートを得た(収率80.6%、純度95.1%)。濾液及び洗液を一緒にして溶媒を留去し、メチルN−(2−アミノ−1,2−ジシアノビニル) ホルムイミデートの二次結晶を2.4g得た(純度26.5%)。
【0015】
実施例2
RMDのRがエチル基であるエチルN−(2−アミノ−1,2−ジシアノビニル)ホルムイミデートの合成
エタノール410mlにDAMN200.0g,トリエチルオルトホルメート301.6gを加え窒素雰囲気下で65℃で2時間、加熱攪拌した。反応液を3℃まで冷却し析出した結晶を濾別した。エタノール60mlで洗浄した後、結晶を真空乾燥して269.1gのエチルN−(2−アミノ−1,2−ジシアノビニル) ホルムイミデートを得た(収率88.6%、純度98.0%)。
濾液及び洗液を一緒にして溶媒を留去し、エチルN−(2−アミノ−1,2−ジシアノビニル) ホルムイミデートの二次結晶を28.5g得た(純度44.6%)。
【0016】
実施例3
エタノール245mlにエチルN−(2−アミノ−1,2−ジシアノビニル) ホルムイミデート40.0gを加えて攪拌しながら,5℃まで冷却、アンモニア23gを2時間かけて吹き込みそのまま7時間攪拌した。過剰のアンモニアを室温、減圧で脱気し5℃まで冷却した。析出した結晶を濾別しエタノール20mlで洗浄し,結晶を真空乾燥して28.1gのAMD{N−(2−アミノ−1,2−ジシアノビニル) ホルムアミジン}を得た (収率85.4%、純度96.9%)。濾液及び洗液を一緒にして溶媒を留去し、AMDの二次結晶を4.4g得た(純度72.3%)。
【0017】
【発明の効果】
ハロゲン系溶媒を使用することなく、アルコール系溶媒種若しくは単一の安価なアルコール系溶媒でしかも簡便な反応操作及び後処理操作で収率よく目的とするN−(2−アミノ−1,2−ジシアノビニル)ギ酸誘導体を充分な純度をもって合成することができる。
[0001]
BACKGROUND OF THE INVENTION
The present invention relates to alkyl N- (2-amino-1,2-dicyanovinyl) formimidate (hereinafter referred to as RMD) and N- (2-amino-1,2-dicyanovinyl) form useful as pharmaceutical intermediates. The present invention relates to a simple and efficient method for producing N- (2-amino-1,2-dicyanovinyl) formic acid derivatives such as amidine (hereinafter referred to as AMD).
[0002]
[Prior art]
N- (2-amino-1,2-dicyanovinyl) formamidine is a useful pharmaceutical intermediate, for example, the precursors of the anticancer drugs dacarbazine and temozolomide, the hepatoprotectant urazamide. There is a need for an efficient synthesis method that is an intermediate raw material of 1H-4 (5) -aminoimidazole-5 (4) -carboxamide (hereinafter abbreviated as AICA in the text).
[0003]
As methods for synthesizing AMD and RMD, the following methods have been known so far.
For AMD, see, for example, R.A. F. Shuman et al. (J. Org. Chem., 1979, 44, 4532) synthesize AMD by heating diaminomaleonitrile (hereinafter abbreviated as DAMN) and formamidine acetate in ethanol at reflux temperature. . However, the yield is only 2%, which is not practical for the industrial production of AMD.
[0004]
Regarding RMD, B.I. L. Booth et al. (J. Chem. Soc. Perkin Trans. I, 1990, 1705) are prepared from diaminomaleonitrile (hereinafter referred to as DAMN) to ethyl N- (2-amino-1,2-dicyanovinyl) formimidate (in the text). (Hereinafter abbreviated as EMD), and then a two-step method for synthesizing AMD from EMD. That is, in the first step, DAMN and triethylorthoformate were reacted in dioxane to synthesize EMD in a yield of 84%. In the second step, the reaction of EMD and ammonia was used, and aniline hydrochloride was used as a catalyst in chloroform. Thus, AMD is synthesized at a yield of 95% by performing at a low temperature of -20 ° C or lower.
[0005]
[Problems to be solved by the invention]
However, this method also has many problems such as complicated reaction operation, low temperature reaction, a large number of solvent types to be used, and possibility of environmental pollution by halogenated solvents, and is insufficient as an industrial production method.
As described above, RMD and AMD manufacturing methods known in the prior art are not satisfactory methods assuming industrial production.
An object of this invention is to provide the novel manufacturing method which manufactures RMD and AMD efficiently cheaply.
[0006]
[Means for Solving the Problems]
As a result of diligent investigations to solve the above problems, the present inventors have made alcohol elimination in the reaction of two steps of producing RMD from DAMN and trialkylorthoformate and then producing AMD from RMD and ammonia. Despite the necessity of removing alcohol from the reaction system in the reaction system, a method for solving many of the above-mentioned problems of the prior art by employing an alcohol-based solvent has been found, and further production of RMD and AMD By adopting the same kind of solvent in the process, an inexpensive method suitable for industrial production was found and the present invention was completed.
[0007]
The present invention relates to AMD {(N- (2-amino-1,2-amino-1,2-dicyanovinyl) formimidate)] which reacts with ammonia in C1-C5 alcohol. -Dicyanovinyl) formamidine}, wherein RMN is produced by reacting DAMN [diaminomaleonitrile] with trialkylorthoformate in C1-C5 alcohol, and further, the obtained RMD is C1-C5 alcohol. It is the manufacturing method of AMD made to react with ammonia in it, Furthermore, it is the manufacturing method of RMD which makes DAMN react with a trialkyl orthoformate in C1-C5 alcohol, and C1-C5 alcohol used at each process is methyl. The production method is alcohol or ethyl alcohol.
[0008]
The reaction formula of the present invention is shown for reference as follows.
In the formula, R represents a lower alkyl group.
[Chemical 1]
[0009]
DETAILED DESCRIPTION OF THE INVENTION
DAMN used in the present invention is an industrially available starting material that can be easily synthesized from a tetramerization reaction of hydrocyanic acid. Another starting material, a trialkylorthoformate, is also an industrially available starting material.
The reaction for synthesizing RMD from DAMN and tolylalkyl orthoformate can be carried out in an alcohol solvent at room temperature to heating. Examples of the alcohol solvent include methanol, ethanol, n-propanol, i-propanol, n-butanol, i-butanol, t-butanol, etc., but solubility of raw materials and products, easy recovery distillation In view of price, methanol and ethanol are particularly preferable.
[0010]
The alkyl group in the trialkyl orthoformate or RMD is preferably a C1-5 lower alkyl group, such as methyl, ethyl, n-propyl, i-propyl, n-butyl, i-butyl, pentyl, Most preferred is methyl or ethyl.
Furthermore, as shown in the above reaction formula, a lower alkyl alcohol derived from the used raw material is by-produced during the reaction. Therefore, it is convenient for separation and recovery to use the same alcohol solvent as the by-product lower alkyl alcohol.
The reaction temperature depends on the reaction time employed, but at low temperatures, the reaction is slow and requires a long time. At high temperatures, the raw material disappears in a short time, but due to an increase in by-products (mainly cyclized product 4,5-dicyanoimidazole). It is necessary to pay attention to the decrease in purity. The reaction temperature is preferably from room temperature to the solvent reflux temperature, and the reaction time is preferably from 30 minutes to 10 hours.
[0011]
After completion of the reaction, RMD is isolated by filtration, but it is preferable to sufficiently precipitate RMD by cooling from 0 ° C. to room temperature in order to reduce RMD dissolved in the solvent and improve the yield.
High purity RMD can be obtained by such a method, but if it is necessary to further increase the purity, it can be purified by recrystallization.
Examples of alcohol solvents for the reaction of synthesizing AMD from RMD and ammonia include methanol, ethanol, n-propanol, i-propanol, n-butanol, i-butanol, t-butanol and the like. Methanol and ethanol are particularly preferable from the standpoints of solubility of the product, ease of recovery distillation, price, and the like.
[0012]
Although the reaction proceeds under cooling and at the solvent reflux temperature, it is preferable to start the reaction under cooling in consideration of the solubility of ammonia and the exotherm during dissolution. The reaction time is preferably 30 minutes to 10 hours.
After the reaction, AMD is isolated by filtration. In order to reduce the amount of AMD dissolved in the solvent and improve the yield, it is preferable that the AMD is sufficiently precipitated by cooling.
High-purity AMD can be obtained by such a method, but if a higher-purity product is required, it can be purified by recrystallization.
[0013]
EXAMPLES Hereinafter, although an Example demonstrates this invention in detail, the scope of the present invention is not limited to an Example.
[0014]
【Example】
Example 1
Synthesis of methyl N- (2-amino-1,2-dicyanovinyl) formimidate wherein RMD of RMD is a methyl group 30.0 g of DAMN and 32.4 g of trimethylorthoformate were added to 60 ml of methanol at 65 ° C. under nitrogen atmosphere. The mixture was heated and stirred for 2 hours. The reaction solution was cooled to 5 ° C., and the precipitated crystals were separated by filtration and washed with 20 ml of methanol. The crystal was dried under vacuum to obtain 33.6 g of methyl N- (2-amino-1,2-dicyanovinyl) formimidate (yield 80.6%, purity 95.1%). The filtrate and washing solution were combined and the solvent was distilled off to obtain 2.4 g of methyl N- (2-amino-1,2-dicyanovinyl) formimidate secondary crystals (purity 26.5%).
[0015]
Example 2
Synthesis of ethyl N- (2-amino-1,2-dicyanovinyl) formimidate in which R of RMD is an ethyl group To 410 ml of ethanol, 200.0 g of DAMN and 301.6 g of triethyl orthoformate were added, and 65 ° C. in a nitrogen atmosphere. And stirred for 2 hours. The reaction solution was cooled to 3 ° C., and the precipitated crystals were separated by filtration. After washing with 60 ml of ethanol, the crystals were vacuum-dried to obtain 269.1 g of ethyl N- (2-amino-1,2-dicyanovinyl) formimidate (yield 88.6%, purity 98.0). %).
The filtrate and washing solution were combined and the solvent was distilled off to obtain 28.5 g of secondary crystals of ethyl N- (2-amino-1,2-dicyanovinyl) formimidate (purity 44.6%).
[0016]
Example 3
Ethyl N- (2-amino-1,2-dicyanovinyl) formimidate (40.0 g) was added to 245 ml of ethanol and the mixture was stirred and cooled to 5 ° C., and 23 g of ammonia was blown in over 2 hours and stirred for 7 hours. Excess ammonia was degassed at room temperature and reduced pressure and cooled to 5 ° C. The precipitated crystals were separated by filtration, washed with 20 ml of ethanol, and the crystals were vacuum-dried to obtain 28.1 g of AMD {N- (2-amino-1,2-dicyanovinyl) formamidine} (yield 85. 4%, purity 96.9%). The filtrate and washing solution were combined and the solvent was distilled off to obtain 4.4 g of AMD secondary crystals (purity 72.3%).
[0017]
【The invention's effect】
Without using a halogen-based solvent, the target N- (2-amino-1,2-) can be obtained in a high yield with a simple reaction operation and post-treatment operation with an alcohol solvent species or a single inexpensive alcohol solvent. Dicyanovinyl) formic acid derivatives can be synthesized with sufficient purity.

Claims (5)

式(I)
(式中、Rは、C1〜5アルキル基を表す。)で表されるアルキルN−(2−アミノ−1,2−ジシアノビニル) ホルムイミデートをC1〜C5アルコール中でアンモニアと反応させる事を特徴とする式(II)
で表されるN−(2−アミノ−1,2−ジシアノビニル) ホルムアミジンの製造方法。
Formula (I)
(In the formula, R represents a C1-5 alkyl group.) An alkyl N- (2-amino-1,2- dicyanovinyl ) formimidate represented by the following formula is reacted with ammonia in a C1-C5 alcohol. Formula (II) characterized by
A method for producing N- (2-amino-1,2-dicyanovinyl) formamidine represented by the formula:
ジアミノマレオニトリルをC1〜C5アルコール中でトリアルキルオルトホルメートと反応させ、式(I)
(式中、Rは、C1〜5アルキル基を表す。)で表されるアルキルN−(2−アミノ−1,2−ジシアノビニル) ホルムイミデートを製造し、さらに、得られたアルキルN−(2−アミノ−1,2−ジシアノビニル) ホルムイミデートをC1〜C5アルコール中でアンモニアと反応させる事を特徴とする式(II)
で表されるN−(2−アミノ−1,2−ジシアノビニル) ホルムアミジンの製造方法。
Diaminomaleonitrile is reacted with a trialkylorthoformate in a C1-C5 alcohol to obtain a compound of formula (I)
(In the formula, R represents a C1-5 alkyl group.) An alkyl N- (2-amino-1,2- dicyanovinyl ) formimidate represented by the formula: (2-Amino-1,2-dicyanovinyl) Formula (II) characterized by reacting formimidate with ammonia in C1-C5 alcohol
A method for producing N- (2-amino-1,2-dicyanovinyl) formamidine represented by the formula:
C1〜C5アルコールがメチルアルコール又はエチルアルコールであることを特徴とする請求項1又は請求項2の製造方法。 The method according to claim 1 or 2, wherein the C1-C5 alcohol is methyl alcohol or ethyl alcohol. ジアミノマレオニトリルをC1〜C5アルコール中でトリアルキルオルトホルメートと反応させる事を特徴とする式(I)
(式中、Rは、C1〜5アルキル基を表す。)で表されるアルキルN−(2−アミノ−1,2−ジシアノビニル) ホルムイミデートの製造方法。
Formula (I) characterized by reacting diaminomaleonitrile with a trialkylorthoformate in a C1-C5 alcohol
(In the formula, R represents a C1-5 alkyl group.) A method for producing an alkyl N- (2-amino-1,2- dicyanovinyl ) formimidate represented by :
C1〜C5アルコールがメチルアルコール又はエチルアルコールであることを特徴とする請求項4に記載のアルキルN−(2−アミノ−1,2−ジシアノビニル) ホルムイミデートの製造方法。 The method for producing alkyl N- (2-amino-1,2-dicyanovinyl) formimidate according to claim 4, wherein the C1-C5 alcohol is methyl alcohol or ethyl alcohol.
JP2000116218A 1999-09-20 2000-04-18 Process for producing N- (2-amino-1,2-dicyanovinyl) formic acid derivative Expired - Fee Related JP4461468B2 (en)

Priority Applications (9)

Application Number Priority Date Filing Date Title
JP2000116218A JP4461468B2 (en) 2000-04-18 2000-04-18 Process for producing N- (2-amino-1,2-dicyanovinyl) formic acid derivative
CNB008131155A CN1150169C (en) 1999-09-20 2000-09-20 Process for the preparation of 4(5)-amino-5(4) carboxamidoimidazoles and intermediates thereof
AT00961096T ATE334972T1 (en) 1999-09-20 2000-09-20 METHOD FOR THE PRODUCTION OF 4(5)-AMINO-5(4)-CARBOXAMIDOIMIDAZOLE AND THEIR INTERMEDIATE PRODUCTS
PCT/JP2000/006397 WO2001021592A1 (en) 1999-09-20 2000-09-20 Processes for the preparation of 4(5)-amino-5(4)-carboxamidoimidazoles and intermediates thereof
CNB2003101214353A CN1238338C (en) 1999-09-20 2000-09-20 Process for the preparation of 4(5)-amino-5(4)carboxamidoimidoimidazoles and intermediates thereof
DE60029803T DE60029803T2 (en) 1999-09-20 2000-09-20 PROCESS FOR THE PREPARATION OF 4 (5) -AMINO-5 (4) -CARBOXAMIDOIMIDAZOLENES AND THEIR INTERMEDIATE PRODUCTS
KR10-2002-7003643A KR100538958B1 (en) 1999-09-20 2000-09-20 Processes for the preparation of 4(5)-amino-5(4)-carboxamidoimidazoles and intermediates thereof
US10/088,425 US6797828B1 (en) 1999-09-20 2000-09-20 Processes for the preparation of 4(5)-amino-5(4)-carboxamidoimidazoles and intermediates thereof
EP00961096A EP1215206B1 (en) 1999-09-20 2000-09-20 Processes for the preparation of 4(5)-amino-5(4)-carboxamidoimidazoles and intermediates thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2000116218A JP4461468B2 (en) 2000-04-18 2000-04-18 Process for producing N- (2-amino-1,2-dicyanovinyl) formic acid derivative

Publications (2)

Publication Number Publication Date
JP2001302609A JP2001302609A (en) 2001-10-31
JP4461468B2 true JP4461468B2 (en) 2010-05-12

Family

ID=18627706

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2000116218A Expired - Fee Related JP4461468B2 (en) 1999-09-20 2000-04-18 Process for producing N- (2-amino-1,2-dicyanovinyl) formic acid derivative

Country Status (1)

Country Link
JP (1) JP4461468B2 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5112737B2 (en) * 2007-04-19 2013-01-09 日本曹達株式会社 Method for producing aminoimidazole derivative
CN102850277A (en) 2007-04-19 2013-01-02 日本曹达株式会社 Method for production of aminoimidazole derivatives

Also Published As

Publication number Publication date
JP2001302609A (en) 2001-10-31

Similar Documents

Publication Publication Date Title
JP4461468B2 (en) Process for producing N- (2-amino-1,2-dicyanovinyl) formic acid derivative
KR100538958B1 (en) Processes for the preparation of 4(5)-amino-5(4)-carboxamidoimidazoles and intermediates thereof
JP4097291B2 (en) Method for producing substituted valinamide derivative
EP0481118B1 (en) A method for producing butyl 3'-(1H-tetrazol-5-yl) oxanilate
CN109956899B (en) Preparation method of vitamin B6
WO2007086076A2 (en) An improved process for preparation of leflunomide
EP1896403A1 (en) An improved process for the preparation of florfenicol
JP4790901B2 (en) Process for producing 4-amino-5-cyanoimidazole derivative and its intermediate
CN112272665A (en) Process for preparing sitagliptin
CN110577520B (en) Preparation method of 6-nitro-4-substituted amino quinazoline derivative
JP4699582B2 (en) Method for producing 1H-4 (5) -aminoimidazole-5 (4) -carboxamide
JP5963222B2 (en) Method for producing DFMB derivative
JPH0535145B2 (en)
JP4768109B2 (en) Process for producing 1H-2-substituted-4 (5) -amino-5 (4) -carboxamide-imidazole
JP5004643B2 (en) Process for producing N- (2-amino-1,2-dicyanovinyl) formamidine
RU2455301C2 (en) Method of producing n-(6-methyl-2,4-dioxo-1,2,3,4-tetrahydro-5-pyrimidine-sulphone)-n′-isonictinoyl hydrazide
KR100199042B1 (en) Process for preparation of 2-aminothiazolecarboxylic acid derivative
RU2190597C2 (en) Method of synthesis of antagonists of nmda (n-methyl-d-aspartate)
JP3592747B2 (en) N-tert-butyl-2,3-pyrazinedicarboxamide and method for producing the same
JP3184745B2 (en) Bisurea compound and method for producing the same
JP3221151B2 (en) Method for producing pyrrole derivatives
JP6169721B2 (en) Method for synthesizing hydrazine that can be used in the treatment of papillomavirus
JP3155909B2 (en) Method for producing 1,3-dialkyl-2-imidazolidinones
KR20050053622A (en) Processes for the preparation of 4(5)-amino-5(4)-carboxamidoimidazoles and intermediates thereof
CN110698420A (en) Preparation method of 2-oxazole methylamine heterocyclic compound

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20061222

A711 Notification of change in applicant

Free format text: JAPANESE INTERMEDIATE CODE: A711

Effective date: 20090313

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20091102

A521 Written amendment

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20091225

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20100125

A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20100207

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20130226

Year of fee payment: 3

R150 Certificate of patent or registration of utility model

Ref document number: 4461468

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

Free format text: JAPANESE INTERMEDIATE CODE: R150

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20130226

Year of fee payment: 3

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20140226

Year of fee payment: 4

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

LAPS Cancellation because of no payment of annual fees